When do we, as a society, have the right or the duty to deny a person's right to work in a chosen profession? The article by Spijkerman et al. 1 in this issue of Infection Control and Hospital Epidemiology once again raises this question. The article reports that a surgeon was unresponsive to repeated attempts at hepatitis B vaccination, and then was infected with hepatitis B at least a decade before discovery through public health department investigations of symptomatic infections among some of his most recent patients. During the course of 4 years, the surgeon, unknowingly infected with hepatitis B virus (HBV), appears to have transmitted HBV to 28 patients.
Since 1970, more than 375 patients worldwide have been infected with hepatitis B from their surgeon. In the United States, 19 patients were infected from a cardiothoracic surgeon who tested positive for both hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg). 2 In 1996, in the United Kingdom, 20 patients were infected from a cardiovascular surgeon who tested positive for HBeAg. 3 In 1994, following hip replacement surgery, a Welsh woman was infected and died of acute hepatitis B that was shown to be genetically identical to her surgeon's hepatitis B; the surgeon tested positive for HBsAg and antibody to hepatitis B e antigen (anti-HBe) and negative for HBeAg. 4 In Canada, an orthopedic surgeon who tested positive for HBeAg infected 4 patients. 5 Now, in this issue, we read that a surgeon from The Netherlands who tested positive for HBsAg and HBeAg infected 28 patients during 4 years. 1 There was transmission to 28 patients during both high-risk and exposure-prone procedures, and also unexpectedly during low-risk procedures. Spijkerman et al. found that the surgeon's infection control practices were adequate; transmission occurred even when no break in infection control procedure or surgical technique occurred.
How do surgeons and other healthcare workers (HCWs) get infected in the first place? Until the early 1980s, hepatitis B was a major occupational risk for HCWs. In 1989, the Center for Disease Control reported an annual rate of 4.89 cases per 1,000 exposed HCWs. 6 In the United States, this translated to more than 12,000 HCWs each year newly acquiring hepatitis B, of whom 25% had clinical illness and 5% to 10% became long-term carriers. There is little to suggest that these rates were different anywhere in the Western world. Other studies have shown that infection rates and subsequent mortality rates were highest among those with the most blood contact (ie, surgeons, pathologists, emergency department staff, and technicians handling blood). Rates increased as a function of age and years of practice. 7, 8 Obviously, our first and foremost line of defense to prevent transmission of HBV from surgeon to patient is to prevent the infection in the surgeon in the first place. The hepatitis B vaccine is both safe and efficacious. It provides immunity for 92% of individuals following a first series, with 5% to 8% remaining poor responders even after additional vaccine. 9 The mere suggestion of mandatory immunization raises many cries. In 1998, when Health Canada proposed mandatory hepatitis B immunization for all HCWs performing exposure-prone procedures, the Canadian Medical Association and the Canadian Dental Association opposed this recommendation. 10 Voluntary, frequently free vaccination has failed miserably in Canada; national surveys suggest that anywhere from 10% to 60% of surgeons and other HCWs who perform invasive procedures are not immunized.
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According to Zou et al. 11 and unpublished data from Health Canada, 5 (11%) of 45 patients with acute hepatitis B in 1999 reported a history of hospitalization; 2 (6.7%) of them had no other risk factors. In 2000, 6 (9.8%) of 61 patients with acute hepatitis B reported a history of hospitalization and 3 (6.3%) reported hospitalization as the exclusive risk factor. Incomplete results for January to October 2001 indicated that 4 (9.3%) of 43 patients reported a history of hospitalization and 1 (2.8%) had hospitalization as the exclusive risk factor. Although not conclusive due to the lack of reference data from the general population, these findings do suggest potential transmission of blood-borne pathogens in healthcare settings in Canada. How many of these "hospitalization" cases might be associated with invasive procedures performed by an HCW infected with hepatitis B?
Few, if any, countries have surveillance systems in place to provide the tracking and linking that is needed to readily and efficiently identify patients infected from their healthcare provider. Most nosocomial hepatitis B series in the literature have been identified by an astute laboratory technician or public health worker who noticed an increase in the number of new cases of hepatitis B in his or her reporting system. This then has led to extensive and expensive look-back studies, not infrequently identifying new cases.
In light of the cases reported in this issue of Infection Control and Hospital Epidemiology 1 (in which both exposure-prone and non-exposure-prone procedures led to infection) and the frequency of nonresponsive and unimmunized HCWs, more restrictive practice modification may need to be considered. These policies may include mandatory programs to promote immunization, ongoing surveillance projects to track nonresponders and those who refuse vaccination, and potential practice restrictions for HBeAg-positive HCWs who perform invasive procedures. 10 For example, Health Canada recommends that, after vaccination, HCWs need to know whether they have obtained adequate antibody protection. 10 If, after repeated attempts at immunization, an HCW is nonresponsive, or if immunization is refused, screening and surveillance programs should be in place to regularly test this HCW for hepatitis B infection. Those found to be positive for HBsAg should be tested for HBeAg. Surgeons and others who perform invasive procedures who test positive for HBeAg may have their practice restricted. Recommendations from Health Canada 10 state that HBeAg-positive HCWs should cease practice until an expert panel (ie, composed of regulatory bodies and professional peers) evaluates their practice to identify modifications that may reduce the risk to patients. Finally, comprehensive surveillance programs that enable linkage from infected patients back to infected HCWs must be established.
Recently, Ross et al. 12 reviewed seven cases of surgeons or anesthesiology staff infected with hepatitis C virus (HCV) transmitting HCV to their patients during the course of medical care. In most cases, patients were infected through inadvertent exposure to the HCWs' blood; only 2 incidents were caused by clear breaches of infection control practices. Ross et al. also detailed a 7-year retrospective study that identified 1 case among 2,286 gynecology patients (0.04%; 95% confidence interval, 0.008% to 0.25%). The transmission rates in these various look-back investigations varied from 0.04% to 2.7%, suggesting that, although infrequent for some surgeons with hepatitis C, transmission to patients has clearly been documented. We need many more in-depth examinations into the risk factors and transmission rates of HCV with different procedures. According to Zou et al. 11 and unpublished data from Health Canada, 15 (18.8%) of 80 patients with acute cases of HCV reported a history of hospitalization and 1 (1.6%) reported it as the exclusive risk factor. For 2000 and January to October 2001, the rates were 21.6% (16 of 74) versus 4.4% (3 of 74) and 14.8% (8 of 54) versus 2.0% (1 of 54), respectively.
For human immunodeficiency virus (HIV), the incidence of transmission from infected HCW to patient is even lower. Six patients were potentially infected by a dentist in Florida during 1984 to 1989. Infection control practices were questionable. 1314 One patient was infected from an orthopedic surgeon in France before 1992. 1516 Unlike the experience with hepatitis B and C, numerous studies and surveillance projects have looked for a link between HIVinfected HCWs and infected patients and have failed to find one.
HCWs who perform invasive procedures of any kind have an ethical obligation to be immunized against hepatitis B and to know their serologic status with reference to HIV, HBV, and HCV. 10 Infected HCWs pose an increasing order of risk to patients if they are HIV-, HCV-, HBsAg-, or HBeAg-positive. Standard precautions appear to be effective in preventing transmission from an HIV-infected HCW. More study is required to identify the most effective, least restrictive modifications in practice and technique to reduce the risk of transmission from HCV-and HBsAg-positive HCWs. On the basis of the study by Spijkerman et al. 1 and previous work done in this area, invasive surgery or other procedures performed by HBeAg-positive HCWs may pose an unacceptable risk to patients that may not be reducible by minor practice changes or enhanced infection control activities.
